Reversal of obesity by targeted ablation of adipose tissue
Top Cited Papers
- 9 May 2004
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 10 (6) , 625-632
- https://doi.org/10.1038/nm1048
Abstract
Obesity is an increasingly prevalent human condition in developed societies. Despite major progress in the understanding of the molecular mechanisms leading to obesity, no safe and effective treatment has yet been found. Here, we report an antiobesity therapy based on targeted induction of apoptosis in the vasculature of adipose tissue. We used in vivo phage display to isolate a peptide motif (sequence CKGGRAKDC) that homes to white fat vasculature. We show that the CKGGRAKDC peptide associates with prohibitin, a multifunctional membrane protein, and establish prohibitin as a vascular marker of adipose tissue. Targeting a proapoptotic peptide to prohibitin in the adipose vasculature caused ablation of white fat. Resorption of established white adipose tissue and normalization of metabolism resulted in rapid obesity reversal without detectable adverse effects. Because prohibitin is also expressed in blood vessels of human white fat, this work may lead to the development of targeted drugs for treatment of obese patients.Keywords
This publication has 39 references indexed in Scilit:
- Extended Longevity in Mice Lacking the Insulin Receptor in Adipose TissueScience, 2003
- Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosisOncogene, 2002
- A Transgenic Model of Visceral Obesity and the Metabolic SyndromeScience, 2001
- Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteinsThe EMBO Journal, 2000
- Addressing tumor blood vesselsNature Biotechnology, 1997
- Organ targeting In vivo using phage display peptide librariesNature, 1996
- Brain Peptides and Obesity: Pharmacologic TreatmentObesity Research, 1995
- Positional cloning of the mouse obese gene and its human homologueNature, 1994
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Physiologic Basis for the Control of Body Fat Distribution in HumansAnnual Review of Nutrition, 1989